Literature DB >> 28492288

Epidemiology of heart failure with preserved ejection fraction.

Shannon M Dunlay1,2, Véronique L Roger1,2, Margaret M Redfield1.   

Abstract

Heart failure (HF) with preserved ejection fraction (HFpEF) is a clinical syndrome associated with poor quality of life, substantial health-care resource utilization, and premature mortality. We summarize the current knowledge regarding the epidemiology of HFpEF with a focus on community-based studies relevant to quantifying the population burden of HFpEF. Current data regarding the prevalence and incidence of HFpEF in the community as well as associated conditions and risk factors, risk of morbidity and mortality after diagnosis, and quality of life are presented. In the community, approximately 50% of patients with HF have HFpEF. Although the age-specific incidence of HF is decreasing, this trend is less dramatic for HFpEF than for HF with reduced ejection fraction (HFrEF). The risk of HFpEF increases sharply with age, but hypertension, obesity, and coronary artery disease are additional risk factors. After adjusting for age and other risk factors, the risk of HFpEF is fairly similar in men and women, whereas the risk of HFrEF is much lower in women. Multimorbidity is common in both types of HF, but slightly more severe in HFpEF. A majority of deaths in patients with HFpEF are cardiovascular, but the proportion of noncardiovascular deaths is higher in HFpEF than HFrEF.

Entities:  

Mesh:

Year:  2017        PMID: 28492288     DOI: 10.1038/nrcardio.2017.65

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN: 1759-5002            Impact factor:   32.419


  116 in total

1.  Prognosis in heart failure with preserved left ventricular systolic function: prospective cohort study.

Authors:  Philip A MacCarthy; Mark T Kearney; James Nolan; Amanda J Lee; Robin J Prescott; Ajay M Shah; W Paul Brooksby; Keith A A Fox
Journal:  BMJ       Date:  2003-07-12

Review 2.  Mode of Death in Heart Failure With Preserved Ejection Fraction.

Authors:  Muthiah Vaduganathan; Ravi B Patel; Alexander Michel; Sanjiv J Shah; Michele Senni; Mihai Gheorghiade; Javed Butler
Journal:  J Am Coll Cardiol       Date:  2017-02-07       Impact factor: 24.094

3.  Comparison of frequencies of left ventricular systolic and diastolic heart failure in Chinese living in Hong Kong.

Authors:  G W Yip; P P Ho; K S Woo; J E Sanderson
Journal:  Am J Cardiol       Date:  1999-09-01       Impact factor: 2.778

4.  Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial.

Authors:  Ali Ahmed; Michael W Rich; Jerome L Fleg; Michael R Zile; James B Young; Dalane W Kitzman; Thomas E Love; Wilbert S Aronow; Kirkwood F Adams; Mihai Gheorghiade
Journal:  Circulation       Date:  2006-07-24       Impact factor: 29.690

5.  Prevalence of chronic heart failure in Southwestern Europe: the EPICA study.

Authors:  Fátima Ceia; Cândida Fonseca; Teresa Mota; Humberto Morais; Fernando Matias; António de Sousa; António Oliveira
Journal:  Eur J Heart Fail       Date:  2002-08       Impact factor: 15.534

6.  Cardiovascular phenotype in HFpEF patients with or without diabetes: a RELAX trial ancillary study.

Authors:  Brian R Lindman; Victor G Dávila-Román; Douglas L Mann; Steven McNulty; Marc J Semigran; Gregory D Lewis; Lisa de las Fuentes; Susan M Joseph; Justin Vader; Adrian F Hernandez; Margaret M Redfield
Journal:  J Am Coll Cardiol       Date:  2014-08-12       Impact factor: 24.094

7.  An investigation of coronary heart disease in families. The Framingham offspring study.

Authors:  W B Kannel; M Feinleib; P M McNamara; R J Garrison; W P Castelli
Journal:  Am J Epidemiol       Date:  1979-09       Impact factor: 4.897

8.  Atrial fibrillation impairs the diagnostic performance of cardiac natriuretic peptides in dyspneic patients: results from the BACH Study (Biomarkers in ACute Heart Failure).

Authors:  Mark Richards; Salvatore Di Somma; Christian Mueller; Richard Nowak; W Frank Peacock; Piotr Ponikowski; Martin Mockel; Christopher Hogan; Alan H B Wu; Paul Clopton; Gerasimos S Filippatos; Inder Anand; Leong Ng; Lori B Daniels; Sean-Xavier Neath; Kevin Shah; Robert Christenson; Oliver Hartmann; Stefan D Anker; Alan Maisel
Journal:  JACC Heart Fail       Date:  2013-06-03       Impact factor: 12.035

9.  Multimorbidity in heart failure: a community perspective.

Authors:  Alanna M Chamberlain; Jennifer L St Sauver; Yariv Gerber; Sheila M Manemann; Cynthia M Boyd; Shannon M Dunlay; Walter A Rocca; Lila J Finney Rutten; Ruoxiang Jiang; Susan A Weston; Véronique L Roger
Journal:  Am J Med       Date:  2014-09-16       Impact factor: 4.965

10.  Irbesartan in patients with heart failure and preserved ejection fraction.

Authors:  Barry M Massie; Peter E Carson; John J McMurray; Michel Komajda; Robert McKelvie; Michael R Zile; Susan Anderson; Mark Donovan; Erik Iverson; Christoph Staiger; Agata Ptaszynska
Journal:  N Engl J Med       Date:  2008-11-11       Impact factor: 91.245

View more
  274 in total

1.  Physical Function, Frailty, Cognition, Depression, and Quality of Life in Hospitalized Adults ≥60 Years With Acute Decompensated Heart Failure With Preserved Versus Reduced Ejection Fraction.

Authors:  Haider J Warraich; Dalane W Kitzman; David J Whellan; Pamela W Duncan; Robert J Mentz; Amy M Pastva; M Benjamin Nelson; Bharathi Upadhya; Gordon R Reeves
Journal:  Circ Heart Fail       Date:  2018-11       Impact factor: 8.790

Review 2.  Unanswered Questions Regarding Blood Pressure Management for HF Prevention.

Authors:  Sergio H R Ramalho; Amil M Shah
Journal:  Curr Hypertens Rep       Date:  2019-01-18       Impact factor: 5.369

3.  Clinical predictors of all-cause mortality in patients presenting to specialist heart failure clinic with raised NT-proBNP and no heart failure.

Authors:  Pankaj Garg; Steven Wood; Andrew J Swift; Graham Fent; Nigel Lewis; Dominic Rogers; Alexander Rothman; Athanasios Charalampopoulos; Abdallah Al-Mohammad
Journal:  ESC Heart Fail       Date:  2020-06-04

Review 4.  Macrophages in Heart Failure with Reduced versus Preserved Ejection Fraction.

Authors:  Matthew DeBerge; Sanjiv J Shah; Lisa Wilsbacher; Edward B Thorp
Journal:  Trends Mol Med       Date:  2019-02-05       Impact factor: 11.951

Review 5.  Cardiorenal syndrome in heart failure with preserved ejection fraction-an under-recognized clinical entity.

Authors:  Akanksha Agrawal; Mario Naranjo; Napatt Kanjanahattakij; Janani Rangaswami; Shuchita Gupta
Journal:  Heart Fail Rev       Date:  2019-07       Impact factor: 4.214

6.  On the search for the right definition of heart failure with preserved ejection fraction.

Authors:  Agnieszka Kapłon-Cieślicka; Karolina Kupczyńska; Piotr Dobrowolski; Błażej Michalski; Miłosz J Jaguszewski; Waldemar Banasiak; Paweł Burchardt; Łukasz Chrzanowski; Szymon Darocha; Justyna Domienik-Karłowicz; Jarosław Drożdż; Marcin Fijałkowski; Krzysztof J Filipiak; Marcin Gruchała; Ewa A Jankowska; Piotr Jankowski; Jarosław D Kasprzak; Wojciech Kosmala; Piotr Lipiec; Przemysław Mitkowski; Katarzyna Mizia-Stec; Piotr Szymański; Agnieszka Tycińska; Wojciech Wańha; Maciej Wybraniec; Adam Witkowski; Piotr Ponikowski; On Behalf Of "Club 30" Of The Polish Cardiac Society
Journal:  Cardiol J       Date:  2020-09-28       Impact factor: 2.737

7.  Effect of Praliciguat on Peak Rate of Oxygen Consumption in Patients With Heart Failure With Preserved Ejection Fraction: The CAPACITY HFpEF Randomized Clinical Trial.

Authors:  James E Udelson; Gregory D Lewis; Sanjiv J Shah; Michael R Zile; Margaret M Redfield; John Burnett; John Parker; Jelena P Seferovic; Phebe Wilson; Robert S Mittleman; Albert T Profy; Marvin A Konstam
Journal:  JAMA       Date:  2020-10-20       Impact factor: 56.272

8.  Ventricular Arrhythmias Underlie Sudden Death in Rats With Heart Failure and Preserved Ejection Fraction.

Authors:  Jae Hyung Cho; Rui Zhang; Stephan Aynaszyan; Kevin Holm; Joshua I Goldhaber; Eduardo Marbán; Eugenio Cingolani
Journal:  Circ Arrhythm Electrophysiol       Date:  2018-08

9.  Mechanisms of atrial fibrillation in aged rats with heart failure with preserved ejection fraction.

Authors:  Thassio Ricardo Ribeiro Mesquita; Rui Zhang; Geoffrey de Couto; Jackelyn Valle; Lizbeth Sanchez; Russell G Rogers; Kevin Holm; Weixin Liu; Eduardo Marbán; Eugenio Cingolani
Journal:  Heart Rhythm       Date:  2020-02-15       Impact factor: 6.343

10.  Reverse electrical remodeling in rats with heart failure and preserved ejection fraction.

Authors:  Jae Hyung Cho; Peter J Kilfoil; Rui Zhang; Ryan E Solymani; Catherine Bresee; Elliot M Kang; Kristin Luther; Russell G Rogers; Geoffrey de Couto; Joshua I Goldhaber; Eduardo Marbán; Eugenio Cingolani
Journal:  JCI Insight       Date:  2018-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.